First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

著者: Glen J. Weiss, Joseph Chao, Jeffrey D. Neidhart, Ramesh K. Ramanathan, Dawn Bassett, James A. Neidhart, Chung Hang Jonathan Choi, Warren Chow, Vincent Chung, Stephen J. Forman, Edward G. Garmey, Jungyeon Hwang, D. Lynn Kalinoski, Marianna Koczywas, Jeff Longmate, Roger J. Melton, Robert J. Morgan, J C Oliver, Joanna Peterkin, John L. Ryan, Thomas Schluep, Timothy W. Synold, Przemyslaw Twardowski, Mark E. Davis, Yun Yen - Investigational New Drugs 2013 被引用: 220